Boy playing on the drums.

What is SKYTROFA®?

SKYTROFA, the first FDA-approved once-weekly pediatric growth hormone injection

Once-weekly SKYTROFA:

Person Icon

Is used to treat growth hormone deficiency (GHD) in children aged 1 year and older who weigh at least 11.5 kg (25.35 lb)

Somatropin Icon

Provides somatropin, which is used in daily growth hormone injections

Icon of arrows extending outward in all directions

Designed to deliver your child’s medicine with extended-release technology

Check Icon

Is FDA-approved, with established safety

Calendar Icon

How SKYTROFA works:

Long-acting, extended release

The innovative technology of SKYTROFA makes once-weekly dosing possible for you and your child

SKYTROFA delivers somatropin, which is used in daily growth hormone therapies. After your child’s SKYTROFA injection, somatropin slowly begins to release over time. This means that your child will get the medicine they need to grow from their injection over the course of a week

Medical Cross Icon

Established safety profile

Once-weekly SKYTROFA has established safety, with no serious side effects due to treatment, as reported in a clinical study

  • In a clinical study, some children taking once-weekly SKYTROFA had mild injection-site reactions
  • None of those children stopped taking SKYTROFA during the study
  • Side effects occurring more frequently than with daily somatropin included viral infection, fever, cough, nausea and vomiting, bleeding, diarrhea, stomach area pain, and joint pain and arthritis
Boy playing with a toy airplane
Resource Discussions Guide

There's no need to dial your weekly dose with SKYTROFA. Watch how to administer your child's medicine using the SKYTROFA Auto-Injector.

Watch video